New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New ...

A new tool that uses information found in patients’ medical records could predict risk for intracranial hemorrhage in ...

Some foods are indeed medicine. Lion's mane mushrooms are a good example, as eating them can improve your heart , gut and brain health. These fungi earn their name from their unique shape -- they look ...

Erin Adelekun, who had a stroke days after giving birth, raises awareness as "Stroke Mama." Her stroke symptoms included a ...

Aussie veterans who helped train Iraqi snipers say they were exposed to hundreds of blasts a day, leaving them with long-term ...

Rates of major bleeding and intracranial hemorrhage are similar for apixaban and dabigatran versus aspirin, while rat ...

In a systematic review and meta-analysis of trials of non-vitamin K oral anticoagulants vs. single antiplatelet therapy, ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

Some clinicians prefer aspirin when balancing bleeding risk with the indication for an anticoagulant, Barnes said, reasoning ...